These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18283131)

  • 1. Is hymenoptera venom allergy an occupational disease?
    Bonadonna P; Schiappoli M; Dama A; Olivieri M; Perbellini L; Senna G; Passalacqua G
    Occup Environ Med; 2008 Mar; 65(3):217-8. PubMed ID: 18283131
    [No Abstract]   [Full Text] [Related]  

  • 2. [Histamine liberation (or histamine release HR): study of the positivity threshold in hymenoptera venom allergy].
    Minkhar M; Giffard G; Lauret MG; Hassoun S; Drouet M; Sainte-Laudy J; Sabbah A
    Allerg Immunol (Paris); 1996 Nov; 28(9):313-6. PubMed ID: 9011170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basophil activation test using flow cytometry in Hymenoptera venom allergy].
    Stevens S; Drouet M; Lauret MG; Loiry M; Sabbah A
    Allerg Immunol (Paris); 1999 Jan; 31(1):11-4. PubMed ID: 10070594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hymenoptera venom allergy. Life-threatening but curable].
    Przybilla B
    Hautarzt; 2008 Mar; 59(3):182-3. PubMed ID: 18259719
    [No Abstract]   [Full Text] [Related]  

  • 5. Occupational allergy to bumble bee venom.
    Josef P
    Clin Exp Allergy; 1993 Oct; 23(10):878. PubMed ID: 10780897
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular in vitro assays in the diagnosis of Hymenoptera venom allergy.
    Scherer K; Weber JM; Jermann TM; Krautheim A; Tas E; Ueberschlag EV; Cammarata M; Bircher AJ
    Int Arch Allergy Immunol; 2008; 146(2):122-32. PubMed ID: 18204278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of allergic reactions to Hymenoptera stings in northern Italy.
    Incorvaia C; Senna G; Mauro M; Bonadonna P; Marconi I; Asero R; Nitti F
    Eur Ann Allergy Clin Immunol; 2004 Dec; 36(10):372-4. PubMed ID: 15662965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy.
    Ruëff F; Bilò MB; Jutel M; Mosbech H; Müller U; Przybilla B;
    J Allergy Clin Immunol; 2009 Jan; 123(1):272-3; author reply 273. PubMed ID: 19130944
    [No Abstract]   [Full Text] [Related]  

  • 10. Asymptomatic sensitization to hymenoptera venom is related to total immunoglobulin E levels.
    Sturm GJ; Schuster C; Kranzelbinder B; Wiednig M; Groselj-Strele A; Aberer W
    Int Arch Allergy Immunol; 2009; 148(3):261-4. PubMed ID: 18849617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.
    Roumana A; Pitsios C; Vartholomaios S; Kompoti E; Kontou-Fili K
    J Allergy Clin Immunol; 2009 Aug; 124(2):379-81. PubMed ID: 19560804
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory animal dander allergy: I. An occupational disease.
    Lutsky II; Neuman I
    Ann Allergy; 1975 Oct; 35(4):201-5. PubMed ID: 1238037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anaphylactic shock and other allergic reactions in persons sensitized to bee venom].
    Rudzki E
    Pol Tyg Lek; 1987 Jun; 42(24):750-2. PubMed ID: 3313317
    [No Abstract]   [Full Text] [Related]  

  • 14. Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy.
    Bonadonna P; Zanotti R; Caruso B; Castellani L; Perbellini O; Colarossi S; Chilosi M; Dama A; Schiappoli M; Pizzolo G; Senna G; Passalacqua G
    J Allergy Clin Immunol; 2008 Jan; 121(1):256-7. PubMed ID: 18206512
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
    Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
    Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and alternative therapy methods for bee and wasp allergy in Van.
    Onbaşi K; Onbaşi O; Eminbeyli L; Kaynak C
    Allergy; 2008 Feb; 63(2):246-7. PubMed ID: 18186819
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prolongation of distal (D.L.) and proximal (P.L.) latencies in the sciatic nerve of the rat after hymenoptera venom injection].
    Fabre F; Rascol O; Didier A; Testut MF; Delisle MB; Leophonte P
    J Toxicol Clin Exp; 1989; 9(6):423-5. PubMed ID: 2634766
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective safety analysis of an ultrarush specific immunotherapy in adults with wasp venom allergy.
    Lee H; Roediger C; Bauer A; Zuberbier T; Worm M
    Allergy; 2006 Oct; 61(10):1237-8. PubMed ID: 16942578
    [No Abstract]   [Full Text] [Related]  

  • 19. Loveless on wasp venom allergy and immunity- part 1.
    Cohen SG
    J Allergy Clin Immunol; 2003 Dec; 112(6):1248-52. PubMed ID: 14657895
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of immediate hypersensitivity reaction with tungsten.
    Miyamoto T; Inoue S; Watanabe T
    Allergy; 2005 Mar; 60(3):415-6. PubMed ID: 15679738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.